XLD Agar Culture Medium Supply

The contract pertains to the supply of pre-packaged Xylose Lysine Deoxycholate XLD Agar in monoplates, specifically designed for the selective isolation of Gram-negative enteric pathogens, a critical component in clinical and public health microbiology laboratories for detecting enteric bacteria such as Salmonella and Shigella. The product must meet stringent quality and performance standards to ensure accurate and reliable pathogen identification, with delivery expected to support the operational needs of the Department of Defense’s Medical Supply Chain under the Medical Supply Chain MD SURG FSF. The solicitation is classified as a subcontract under NAICS code 325414, which corresponds to the manufacturing of other pharmaceutical and medicinal products, indicating that the supplier must have appropriate capabilities in sterile, controlled-environment production of diagnostic culture media. The opportunity was posted on July 20, 2026, with a response deadline of July 27, 2026, providing a limited seven-day window for interested parties to submit proposals. The place of performance is designated as FPO, 09566-4008, indicating delivery to a military postal facility, likely supporting overseas or mobile military medical units. The contract does not include a set-aside designation or specific point of contact, suggesting it is open to qualified commercial suppliers without preference for small, minority-owned, or other disadvantaged businesses. Procurement is managed through the DLA Dibbs platform, with the official solicitation accessible via the provided URL, requiring potential bidders to review full technical specifications and compliance requirements directly on the site to ensure alignment with military and regulatory standards for diagnostic microbiology reagents.